Caris Life Sciences (CAI) Gross Margin (2024 - 2026)

Caris Life Sciences (CAI) posted quarterly Gross Margin of 99.1% for Q1 2026, up 4946.0% year-over-year from 1.96% in Q1 2025, and up 659.21% quarter-over-quarter from 13.05% in Q4 2025.

Caris Life Sciences (CAI) Gross Margin (2024 - 2026) Analysis & Trends

Caris Life Sciences' Gross Margin history runs 3 years deep, the most recent figure standing at 99.1% for Q1 2026.

  • In Q1 2026, Gross Margin rose 4946.0% year-over-year to 99.1%; the TTM figure through Mar 2026 stood at 57.14% (down 1589.0% YoY), while the FY2025 annual figure was 67.69%, down 2978.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 99.1%, up from 13.05% in the prior quarter.
  • The five-year high for Gross Margin was 99.1% in Q1 2026, with the low at 13.05% in Q4 2025.
  • The 3-year median for Gross Margin is 66.55% (2025), against an average of 66.92%.
  • The sharpest annual moves came in 2025 and 2026: Gross Margin sank 8443 bps in 2025, then jumped 4946 bps in 2026.
  • Caris Life Sciences' Gross Margin stood at 97.48% in 2024, then slumped by 87 bps to 13.05% in 2025, then surged by 659 bps to 99.1% in 2026.
  • Business Quant data shows CAI's Gross Margin at 99.1% in Q1 2026, 13.05% in Q4 2025, and 69.11% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 91.59%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 90.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 89.76%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 60,631,834.75%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 76.90%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 84.20%
10 Caris Life Sciences 6.16 Bn 5.37 Bn 182.38 Mn 69.16%

Historic Data

Download Data
DateValue
Jun 30, 2026 69.16%
Mar 31, 2026 99.10%
Dec 31, 2025 13.05%
Sep 30, 2025 69.11%
Jun 30, 2025 63.99%
Mar 31, 2025 49.64%
Dec 31, 2024 97.48%
Sep 30, 2024 46.06%
Jun 30, 2024 96.94%